ArticleProceedings of the National Academy of Sciences of the United States of America2026

RHAMM drives formation of polyploid cancer cells and confers resistance to ER-targeted therapy in breast cancer.

Shiyi Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.